Journal of Cancer Research and Therapeutics Close
 

Figure 4: Before (a) and after (b) propensity score matching, the 1-, 3-, and 5-year recurrence-free survival rates in the microwave ablation only group were compared with those in the transarterial chemoembolization combined with microwave ablation group (P = 0.786, P = 0.689)

Figure 4: Before (a) and after (b) propensity score matching, the 1-, 3-, and 5-year recurrence-free survival rates in the microwave ablation only group were compared with those in the transarterial chemoembolization combined with microwave ablation group (<i>P</i> = 0.786, <i>P</i> = 0.689)